New Understanding of How Genetic Mutation Causes Huntington’s Disease

BTK Inhibitors in the Presence of 17p Deletions or TP53 Mutation in CLL | CancerNetwork

A New Revolutionary Unifying Theory That Could Redefine Cancer Treatment Worldwide At FLOGEN SIPS 2025, Davis Joseph, Director of Biochemistry at FLOGEN Technologies Inc., Canada, and Research Associate at Gifu University, Japan, presented a groundbreaking unifying theory for cancer treatment that challenges decades of organ-based oncology. Instead of classifying cancer by where it appears in the body, his framework categorizes all cancers by shared molecular mechanisms controlling cell death. T

The Cancer Genome Atlas (TCGA)

The Sidney Kimmel Comprehensive Cancer Center